Abstract
Diabetic neuropathy is one of the prevalent and debilitating microvascular complications of diabetes mellitus, affecting a significant portion of the global population. Relational preclinical animal models are essential to understand its pathophysiology and develop effective treatments. This abstract provides an overview of current knowledge and advancements in such models. Various animal models have been developed to mimic the multifaceted aspects of human diabetic neuropathy, including both type 1 and type 2 diabetes. These models involve rodents (rats and mice) and larger animals like rabbits and dogs. Induction of diabetic neuropathy in these models is achieved through chemical, genetic, or dietary interventions, such as diabetogenic agents, genetic modifications, or high-fat diets. Preclinical animal models have greatly contributed to studying the intricate molecular and cellular mechanisms underlying diabetic neuropathy. They have shed light on hyperglycemia-induced oxidative stress, neuroinflammation, mitochondrial dysfunction, and altered neurotrophic factor signaling. Additionally, these models have allowed for the investigation of morphological changes, functional alterations, and behavioral manifestations associated with diabetic neuropathy. These models have also been crucial for evaluating the efficacy and safety of potential therapeutic interventions. Novel pharmacological agents, gene therapies, stem cell-based approaches, exercise, dietary modifications, and neurostimulation techniques have been tested using these models. However, limitations and challenges remain, including physiological differences between humans and animals, complex neuropathy phenotypes, and the need for translational validation. In conclusion, preclinical animal models have played a vital role in advancing our understanding and management of diabetic neuropathy. They have enhanced our knowledge of disease mechanisms, facilitated the development of novel treatments, and provided a platform for translational research. Ongoing efforts to refine and validate these models are crucial for future treatment developments for this debilitating condition.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Not applicable
References
Akter S, Choubey M, Mohib MM, Arbee S, Sagor MAT, Mohiuddin MS (2023) Stem cell therapy in diabetic polyneuropathy: recent advancements and future directions. Brain Sci 13(2):255. https://doi.org/10.3390/brainsci13020255
Al-Awar A, Kupai K, Veszelka M, Szűcs G, Attieh Z, Murlasits Z, Török S, Pósa A, Varga C (2016) Experimental diabetes mellitus in different animal models. J Diabetes Res 2016:9051426. https://doi.org/10.1155/2016/9051426
Andersen H (2012) Motor dysfunction in diabetes. Diabetes Metab Res Rev 28(Suppl 1):89–92. https://doi.org/10.1002/dmrr.2257
Arndt T, Jörns A, Hedrich HJ, Lenzen S, Wedekind D (2014) Variable immune cell frequencies in peripheral blood of LEW.1AR1-iddm rats over time compared to other congenic LEW strains. Clin Exp Immunol 177(1):168–178. https://doi.org/10.1111/cei.12323
Azushima K, Gurley SB, Coffman TM (2018) Modelling diabetic nephropathy in mice. Nat Rev Nephrol 14(1):48–56. https://doi.org/10.1038/nrneph.2017.142
Baek HS, Yoon JW (1991) Direct involvement of macrophages in destruction of beta-cells leading to development of diabetes in virus-infected mice. Diabetes 40(12):1586–1597. https://doi.org/10.2337/diab.40.12.1586
Beydag-Tasöz BS, Yennek S, Grapin-Botton A (2023) Towards a better understanding of diabetes mellitus using organoid models. Nat Rev Endocrinol 19(4):232–248. https://doi.org/10.1038/s41574-022-00797-x
Biessels GJ, Deary IJ, Ryan CM (2008) Cognition and diabetes: a lifespan perspective. Lancet Neurol 7(2):184–90. https://doi.org/10.1016/S1474-4422(08)70021-8
Biessels GJ, Bril V, Calcutt NA, Cameron NE, Cotter MA, Dobrowsky R, Feldman EL, Fernyhough P, Jakobsen J, Malik RA, Mizisin AP, Oates PJ, Obrosova IG, Pop-Busui R, Russell JW, Sima AA, Stevens MJ, Schmidt RE, Tesfaye S, Veves A, Zochodne DW (2014) Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab). J Peripher Nerv Syst: JPNS 19(2):77–87. https://doi.org/10.1111/jns5.12072
Bodman MA, Varacallo M. Peripheral diabetic neuropathy. [Updated 2023 Aug 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK442009/
Bonner-Weir S, Trent DF, Weir GC (1983) Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. J Clin Investig 71(6):1544–1553. https://doi.org/10.1172/jci110910
Bosma FK, Kessels RP (2002) Cognitive impairments, psychological dysfunction, and coping styles in patients with chronic whiplash syndrome. Neuropsychiatry Neuropsychol Behav Neurol 15(1):56–65
Boullion RD, Mokelke EA, Wamhoff BR, Otis CR, Wenzel J, Dixon JL, Sturek M (2003) Porcine model of diabetic dyslipidemia: insulin and feed algorithms for mimicking diabetes mellitus in humans. Comp Med 53(1):42–52
Boulton AJ (2012) Diabetic neuropathy: is pain God’s greatest gift to mankind? Semin Vasc Surg 25(2):61–65. https://doi.org/10.1053/j.semvascsurg.2012.04.009
Boulton AJ, Drury J, Clarke B, Ward JD (1982) Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 5(4):386–390. https://doi.org/10.2337/diacare.5.4.386
Boulton AJ, Malik RA, Arezzo JC, Sosenko JM (2004) Diabetic somatic neuropathies. Diabetes Care 27(6):1458–1486. https://doi.org/10.2337/diacare.27.6.1458
Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D, American Diabetes Association (2005) Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28(4):956–962. https://doi.org/10.2337/diacare.28.4.956
Bremer AA, Stanhope KL, Graham JL, Cummings BP, Wang W, Saville BR, Havel PJ (2011) Fructose-fed rhesus monkeys: a nonhuman primate model of insulin resistance, metabolic syndrome, and type 2 diabetes. Clin Transl Sci 4(4):243–252. https://doi.org/10.1111/j.1752-8062.2011.00298.x
Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414(6865):813–820. https://doi.org/10.1038/414813a
Bryda EC (2013) The mighty mouse: the impact of rodents on advances in biomedical research. Mo Med 110(3):207–211
Cameron NE, Eaton SE, Cotter MA, Tesfaye S (2001) Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 44(11):1973–1988. https://doi.org/10.1007/s001250100001
Chatzigeorgiou A, Halapas A, Kalafatakis K, Kamper E (2009) The use of animal models in the study of diabetes mellitus. In Vivo (Athens, Greece) 23(2):245–258
Chen D, Wang MW (2005) Development and application of rodent models for type 2 diabetes. Diabetes Obes Metab 7(4):307–317. https://doi.org/10.1111/j.1463-1326.2004.00392.x
Chen W, Zhou XB, Liu HY, Xu C, Wang LL, Li S (2009) P633H, a novel dual agonist at peroxisome proliferator-activated receptors alpha and gamma, with different anti-diabetic effects in db/db and KK-Ay mice. Br J Pharmacol 157(5):724–735. https://doi.org/10.1111/j.1476-5381.2009.00231.x
Den Broeder MJ, Kopylova VA, Kamminga LM, Legler J (2015) Zebrafish as a model to study the role of peroxisome proliferating-activated receptors in adipogenesis and obesity. PPAR Res 2015:358029. https://doi.org/10.1155/2015/358029
Dick BD, Rashiq S (2007). Disruption of attention and working memory traces in individuals with chronic pain. Anesth Analg 104(5). https://doi.org/10.1213/01.ane.0000263280.49786.f5
Dufrane D, van Steenberghe M, Guiot Y, Goebbels RM, Saliez A, Gianello P (2006) Streptozotocin-induced diabetes in large animals (pigs/primates): role of GLUT2 transporter and beta-cell plasticity. Transplantation 81(1):36–45. https://doi.org/10.1097/01.tp.0000189712.74495.82
Eileen Dolan M (1997) Inhibition of DNA repair as a means of increasing the antitumor activity of DNA reactive agents. Adv Drug Deliv Rev 26(2–3):105–118. https://doi.org/10.1016/s0169-409x(97)00028-8
Eleazu CO, Eleazu KC, Chukwuma S, Essien UN (2013) Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans. J Diabetes Metab Disord 12(1):60. https://doi.org/10.1186/2251-6581-12-60
Ellis TM, Atkinson MA (1996) The clinical significance of an autoimmune response against glutamic acid decarboxylase. Nat Med 2(2):148–153. https://doi.org/10.1038/nm0296-148
Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S (2000) Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia 43(12):1528–1533. https://doi.org/10.1007/s001250051564
Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, Bril V, Russell JW, Viswanathan V (2019) Diabetic neuropathy. Nat Rev Dis Primers 5(1):42. https://doi.org/10.1038/s41572-019-0097-9
Filippi CM, von Herrath MG (2008) Viral trigger for type 1 diabetes: pros and cons. Diabetes 57(11):2863–2871. https://doi.org/10.2337/db07-1023
Furman BL (2015) Streptozotocin-induced diabetic models in mice and rats. Curr Protoc Pharmacol 70:5.47.1-5.47.20. https://doi.org/10.1002/0471141755.ph0547s70
Garnett KE, Chapman P, Chambers JA, Waddell ID, Boam DS (2005) Differential gene expression between Zucker fatty rats and Zucker diabetic fatty rats: a potential role for the immediate-early gene Egr-1 in regulation of beta cell proliferation. J Mol Endocrinol 35(1):13–25. https://doi.org/10.1677/jme.1.01792
Gibbons CH, Freeman R (2010) Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy. Ann Neurol 67(4):534–541. https://doi.org/10.1002/ana.21952
Giri B, Dey S, Das T, Sarkar M, Banerjee J, Dash SK (2018) Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: an update on glucose toxicity. Biomed Pharmacother 107:306–328. https://doi.org/10.1016/j.biopha.2018.07.157
Gómez Dumm CL, Semino MC, Gagliardino JJ (1990) Sequential morphological changes in pancreatic islets of spontaneously diabetic rats. Pancreas 5(5):533–539. https://doi.org/10.1097/00006676-199009000-00007
Goto Y, Kakizaki M, Masaki N (1976) Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J Exp Med 119(1):85–90. https://doi.org/10.1620/tjem.119.85
Graham ML, Janecek JL, Kittredge JA, Hering BJ, Schuurman HJ (2011) The streptozotocin-induced diabetic nude mouse model: differences between animals from different sources. Comp Med 61(4):356–360
Guberski DL, Thomas VA, Shek WR, Like AA, Handler ES, Rossini AA, Wallace JE, Welsh RM (1991) Induction of type I diabetes by Kilham’s rat virus in diabetes-resistant BB/Wor rats. Science (New York, N.Y.) 254(5034):1010–1013. https://doi.org/10.1126/science.1658938
Gutierrez J, Palma JA, Kaufmann H (2020) Acute sensory and autonomic neuronopathy: a devastating disorder affecting sensory and autonomic ganglia. Semin Neurol 40(5):580–590. https://doi.org/10.1055/s-0040-1713843
Hansen BC, Bodkin NL (1986) Heterogeneity of insulin responses: phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey. Diabetologia 29(10):713–719. https://doi.org/10.1007/BF00870281
Hao W, Tashiro S, Hasegawa T, Sato Y, Kobayashi T, Tando T, Katsuyama E, Fujie A, Watanabe R, Morita M, Miyamoto K, Morioka H, Nakamura M, Matsumoto M, Amizuka N, Toyama Y, Miyamoto T (2015) Hyperglycemia promotes Schwann cell de-differentiation and de-myelination via sorbitol accumulation and Igf1 protein down-regulation. J Biol Chem 290(28):17106–17115. https://doi.org/10.1074/jbc.M114.631291
Hartoft-Nielsen ML, Rasmussen AK, Bock T, Feldt-Rasmussen U, Kaas A, Buschard K (2009) Iodine and tri-iodo-thyronine reduce the incidence of type 1 diabetes mellitus in the autoimmune prone BB rats. Autoimmunity 42(2):131–138. https://doi.org/10.1080/08916930802438774
Hattangady NG, Rajadhyaksha MS (2009) A brief review of in vitro models of diabetic neuropathy. Int J Diabetes Dev Ctries 29(4):143–149. https://doi.org/10.4103/0973-3930.57344
Heydemann A (2016) An overview of murine high fat diet as a model for type 2 diabetes mellitus. J Diabetes Res 2016:2902351. https://doi.org/10.1155/2016/2902351
Hicks CW, Selvin E (2019) Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diabetes Rep 19(10):86. https://doi.org/10.1007/s11892-019-1212-8
Holmberg R, Refai E, Höög A, Crooke RM, Graham M, Olivecrona G, Berggren PO, Juntti-Berggren L (2011) Lowering apolipoprotein CIII delays onset of type 1 diabetes. Proc Natl Acad Sci U. S. A 108(26):10685–10689. https://doi.org/10.1073/pnas.1019553108
Hummel KP, Dickie MM, Coleman DL (1966) Diabetes, a new mutation in the mouse. Science (New York, N. Y.) 153(3740):1127–1128. https://doi.org/10.1126/science.153.3740.1127
Iannaccone PM, Jacob HJ (2009) Rats! Dis Models Mech 2(5–6):206–210. https://doi.org/10.1242/dmm.002733
Ikeda H (1994) KK mouse. Diabetes Res Clin Pract 24(Suppl):S313–S316. https://doi.org/10.1016/0168-8227(94)90268-2
International Silkworm Genome Consortium (2008) The genome of a lepidopteran model insect, the silkworm Bombyx mori. Insect Biochem Mol Biol 38(12):1036–1045. https://doi.org/10.1016/j.ibmb.2008.11.004
Ishida K, Mizuno A, Min Z, Sano T, Shima K (1995) Which is the primary etiologic event in Otsuka Long-Evans Tokushima fatty rats, a model of spontaneous non-insulin-dependent diabetes mellitus, insulin resistance, or impaired insulin secretion? Metabolism 44(7):940–945. https://doi.org/10.1016/0026-0495(95)90249-x
Islam MS (2013) Animal models of diabetic neuropathy: progress since 1960s. J Diabetes Res 2013:149452. https://doi.org/10.1155/2013/149452
Islam MS, Loots duT (2009) Experimental rodent models of type 2 diabetes: a review. Methods Find Exp Clin Pharmacol 31(4):249–261. https://doi.org/10.1358/mf.2009.31.4.1362513
Jorge LL, Gerard C, Revel M (2009) Evidences of memory dysfunction and maladaptive coping in chronic low back pain and rheumatoid arthritis patients: challenges for rehabilitation. Eur J Phys Rehab Med 45(4):469–477
Jörns A, Günther A, Hedrich HJ, Wedekind D, Tiedge M, Lenzen S (2005) Immune cell infiltration, cytokine expression, and beta-cell apoptosis during the development of type 1 diabetes in the spontaneously diabetic LEW.1AR1/Ztm-iddm rat. Diabetes 54(7):2041–2052. https://doi.org/10.2337/diabetes.54.7.2041
Kalichman MW, Dines KC, Bobik M, Mizisin AP (1998) Nerve conduction velocity, laser Doppler flow, and axonal caliber in galactose and streptozotocin diabetes. Brain Res 810(1–2):130–137. https://doi.org/10.1016/s0006-8993(98)00898-1
Kanaani J, Diacovo MJ, El-Husseini A.el-D, Bredt DS, Baekkeskov S (2004) Palmitoylation controls trafficking of GAD65 from Golgi membranes to axon-specific endosomes and a Rab5a-dependent pathway to presynaptic clusters. J Cell Sci 117(Pt 10):2001–2013. https://doi.org/10.1242/jcs.01030
Kane JD, Steinbach TJ, Sturdivant RX, Burks RE (2012) Sex-associated effects on hematologic and serum chemistry analytes in sand rats (Psammomys obesus). J Am Assoc Lab Anim Sci: JAALAS 51(6):769–774
Katoh M, Sakurai K, Fujimoto Y (2002) Yakugaku zasshi 122(10):831–839. https://doi.org/10.1248/yakushi.122.831
Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T (1991) New inbred strain of Long-Evans Tokushima lean rats with IDDM without lymphopenia. Diabetes 40(11):1375–1381. https://doi.org/10.2337/diab.40.11.1375
King AJ (2012) The use of animal models in diabetes research. Br J Pharmacol 166(3):877–894. https://doi.org/10.1111/j.1476-5381.2012.01911.x
Koletsky S (1973) Obese spontaneously hypertensive rats–a model for study of atherosclerosis. Exp Mol Pathol 19(1):53–60. https://doi.org/10.1016/0014-4800(73)90040-3
Komeda K, Noda M, Terao K, Kuzuya N, Kanazawa M, Kanazawa Y (1998) Establishment of two substrains, diabetes-prone and non-diabetic, from Long-Evans Tokushima Lean (LETL) rats. Endocr J 45(6):737–744. https://doi.org/10.1507/endocrj.45.737
Kong LL, Wu H, Cui WP, Zhou WH, Luo P, Sun J, Yuan H, Miao LN (2013) Advances in murine models of diabetic nephropathy. J Diabetes Res 2013:797548. https://doi.org/10.1155/2013/797548
Kumar S, Singh R, Vasudeva N, Sharma S (2012) Acute and chronic animal models for the evaluation of anti-diabetic agents. Cardiovasc Diabetol 11:9. https://doi.org/10.1186/1475-2840-11-9
Lenzen S (2008) The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51(2):216–226. https://doi.org/10.1007/s00125-007-0886-7
Lenzen S, Tiedge M, Elsner M, Lortz S, Weiss H, Jörns A, Klöppel G, Wedekind D, Prokop CM, Hedrich HJ (2001) The LEW.1AR1/Ztm-iddm rat: a new model of spontaneous insulin-dependent diabetes mellitus. Diabetologia 44(9):1189–1196. https://doi.org/10.1007/s001250100625
Li C, Bunner EA, Pippi JJ (2013) From animal models to clinical practicality: lessons learned from current translational progress of diabetic peripheral neuropathy. InTech. https://doi.org/10.5772/55364
Lieschke GJ, Currie PD (2007) Animal models of human disease: zebrafish swim into view. Nat Rev Genet 8(5):353–367. https://doi.org/10.1038/nrg2091
Magadmi RM, Alsulaimani MA, Al-Rafiah AR, Esmat A (2021) The neuroprotective effect of carvedilol on diabetic neuropathy: an in vitro study. J Diabetes Res 2021:6927025. https://doi.org/10.1155/2021/6927025
Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y (1980) Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29(1):1–13. https://doi.org/10.1538/expanim1978.29.1_1
Marquié G, Hadjiisky P, Arnaud O, Duhault J (1991) Development of macroangiopathy in sand rats (Psammomys obesus), an animal model of non-insulin-dependent diabetes mellitus: effect of gliclazide. Am J Med 90(6A):55S-61S. https://doi.org/10.1016/0002-9343(91)90419-x
Mathews CE (2005) Utility of murine models for the study of spontaneous autoimmune type 1 diabetes. Pediatr Diabetes 6(3):165–177. https://doi.org/10.1111/j.1399-543X.2005.00123.x
Matveyenko AV, Butler PC (2006) Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes. ILAR J 47(3):225–233. https://doi.org/10.1093/ilar.47.3.225
Meier H, Yerganian G (1961) Spontaneous hereditary diabetes mellitus in the Chinese hamster (Cricetulus griseus). III. Maintenance of a diabetic hamster colony with the aid of hypoglycemic therapy. Diabetes 10:19–21. https://doi.org/10.2337/diab.10.1.19
Meng X, Zhu F, Chen K (2017) Silkworm: a promising model organism in life science. J Insect Sci (Online) 17(5):97. https://doi.org/10.1093/jisesa/iex064
Mordes JP, Bortell R, Blankenhorn EP, Rossini AA, Greiner DL (2004) Rat models of type 1 diabetes: genetics, environment, and autoimmunity. ILAR J 45(3):278–291. https://doi.org/10.1093/ilar.45.3.278
Mordes JP, Guberski DL, Leif JH, Woda BA, Flanagan JF, Greiner DL, Kislauskis EH, Tirabassi RS (2005) LEW.1WR1 rats develop autoimmune diabetes spontaneously and in response to environmental perturbation. Diabetes 54(9):2727–2733. https://doi.org/10.2337/diabetes.54.9.2727
Movassat J, Calderari S, Fernández E, Martín MA, Escrivá F, Plachot C, Gangnerau MN, Serradas P, Alvarez C, Portha B (2007) Type 2 diabetes - a matter of failing beta-cell neogenesis? Clues from the GK rat model. Diabetes Obes Metab 9(Suppl 2):187–195. https://doi.org/10.1111/j.1463-1326.2007.00786.x
Nadar MS, Jasem Z, Manee FS (2016) The cognitive functions in adults with chronic pain: a comparative study. Pain Res Manag 2016:5719380. https://doi.org/10.1155/2016/5719380
Nardini C (2014) The ethics of clinical trials. Ecancermedicalscience 16(8):387. https://doi.org/10.3332/ecancer.2014.387
Natori T, Kawano K (1993) The LETL rat: a model for IDDM without lymphopenia. ILAR J 35(1):15–18. https://doi.org/10.1093/ilar.35.1.15
Nie J, Xue B, Sukumaran S, Jusko WJ, Dubois DC, Almon RR (2011) Differential muscle gene expression as a function of disease progression in Goto-Kakizaki diabetic rats. Mol Cell Endocrinol 338(1–2):10–17. https://doi.org/10.1016/j.mce.2011.02.016
Obrosova IG (2009) Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics 6(4):638–647. https://doi.org/10.1016/j.nurt.2009.07.004
Obrosova IG, Ilnytska O, Lyzogubov VV, Pavlov IA, Mashtalir N, Nadler JL, Drel VR (2007) High-fat diet induced neuropathy of pre-diabetes and obesity: effects of “healthy” diet and aldose reductase inhibition. Diabetes 56(10):2598–2608. https://doi.org/10.2337/db06-1176
Oka T, Nishimura Y, Zang L, Hirano M, Shimada Y, Wang Z, Umemoto N, Kuroyanagi J, Nishimura N, Tanaka T (2010) Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity. BMC Physiol 10:21. https://doi.org/10.1186/1472-6793-10-21
Paik SG, Fleischer N, Shin SI (1980) Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes. Proc Natl Acad Sci U. S. A 77(10):6129–6133. https://doi.org/10.1073/pnas.77.10.6129
Pang L, Lian X, Liu H, Zhang Y, Li Q, Cai Y, Ma H, Yu X (2020) Understanding diabetic neuropathy: focus on oxidative stress. Oxid Med Cell Longev 2020:9524635. https://doi.org/10.1155/2020/9524635
Pearson JA, Wong FS, Wen L (2016) The importance of the non obese diabetic (NOD) mouse model in autoimmune diabetes. J Autoimmun 66:76–88. https://doi.org/10.1016/j.jaut.2015.08.019
Peltonen L, McKusick VA (2001) Genomics and medicine. Dissecting human disease in the postgenomic era. Science (New York, N. Y.) 291(5507):1224–1229. https://doi.org/10.1126/science.291.5507.1224
Phillips RW, Panepinto LM, Spangler R, Westmoreland N (1982) Yucatan miniature swine as a model for the study of human diabetes mellitus. Diabetes 31(Suppl 1 Pt 2):30–36. https://doi.org/10.2337/diab.31.1.s30
Phillips MS, Liu Q, Hammond HA, Dugan V, Hey PJ, Caskey CJ, Hess JF (1996) Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet 13(1):18–19. https://doi.org/10.1038/ng0596-18
Piliponienė L, Veličkienė D, Kregždytė R (2021) Microvascular complications, peripheral artery disease and mortality in patients with type 2 diabetes mellitus, in two counties of southern Lithuania over 13 years: analysis using a cohort database of the National Health Insurance. Medicina 57(12):1380. MDPI AG. Retrieved from https://doi.org/10.3390/medicina57121380
Pittenger GL, Mehrabyan A, Simmons K, Amandarice, Dublin C, Barlow P, Vinik AI (2005) Small fiber neuropathy is associated with the metabolic syndrome. Metab Syndr Relat Disord 3(2):113–121. https://doi.org/10.1089/met.2005.3.113
Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D (2017) Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care 40(1):136–154. https://doi.org/10.2337/dc16-2042
Portha B (2005) Programmed disorders of beta-cell development and function as one cause for type 2 diabetes? The GK rat paradigm. Diabetes Metab Res Rev 21(6):495–504. https://doi.org/10.1002/dmrr.566
Portha B, Lacraz G, Kergoat M, Homo-Delarche F, Giroix MH, Bailbé D, Gangnerau MN, Dolz M, Tourrel-Cuzin C, Movassat J (2009) The GK rat beta-cell: a prototype for the diseased human beta-cell in type 2 diabetes? Mol Cell Endocrinol 297(1–2):73–85. https://doi.org/10.1016/j.mce.2008.06.013
Portha B, Giroix MH, Tourrel-Cuzin C, Le-Stunff H, Movassat J (2012) The GK rat: a prototype for the study of non-overweight type 2 diabetes. Methods Mol Biol (Clifton, N.J.) 933:125–159. https://doi.org/10.1007/978-1-62703-068-7_9
Preguiça I, Alves A, Nunes S, Gomes P, Fernandes R, Viana SD, Reis F (2020) Diet-induced rodent models of diabetic peripheral neuropathy, retinopathy and nephropathy. Nutrients 12(1):250. https://doi.org/10.3390/nu12010250
Prins JB, Herberg L, Den Bieman M, van Zutphen LF (1991) Genetic variation within and between lines of diabetes-prone and non-diabetes-prone BB rats; allele distribution of 8 protein markers. Lab Anim 25(3):207–211. https://doi.org/10.1258/002367791780808446
Rakieten N, Rakieten ML, Nadkarni MV (1963) Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep 29:91–98
Rerup CC (1970) Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 22(4):485–518
Richardson IM, Calo CJ, Hind LE (2021) Microphysiological systems for studying cellular crosstalk during the neutrophil response to infection. Front Immunol 12:661537. https://doi.org/10.3389/fimmu.2021.661537
Rodrigues Filho OA, Fazan VP (2006) Streptozotocin induced diabetes as a model of phrenic nerve neuropathy in rats. J Neurosci Methods 151(2):131–138. https://doi.org/10.1016/j.jneumeth.2005.06.024
Rohilla A, Ali S (2012) Alloxan induced diabetes: mechanisms and effects. Int J Res Pharmaceut Biomed Sci 3(2):819–23
Schmidt RE, Dorsey DA, Beaudet LN, Peterson RG (2003) Analysis of the Zucker diabetic datty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy. Am J Pathol 163(1):21–28. https://doi.org/10.1016/S0002-9440(10)63626-7
Scuteri D, Hamamura K, Watanabe C, Tonin P, Bagetta G, Corasaniti MT (2022) Transgenic mice for the translational study of neuropathic pain and dystonia. Int J Mol Sci 23(15):8580. https://doi.org/10.3390/ijms23158580
Shafrir E, Ziv E, Kalman R (2006) Nutritionally induced diabetes in desert rodents as models of type 2 diabetes: Acomys cahirinus (spiny mice) and Psammomys obesus (desert gerbil). ILAR J 47(3):212–224. https://doi.org/10.1093/ilar.47.3.212
Shaikh AS, Somani RS (2010) Animal models and biomarkers of neuropathy in diabetic rodents. Indian J Pharmacol 42(3):129–134. https://doi.org/10.4103/0253-7613.66833
Sharma AK, Thomas PK, Baker RW (1976) Peripheral nerve abnormalities related to galactose administration in rats. J Neurol Neurosurg Psychiatry 39(8):794–802. https://doi.org/10.1136/jnnp.39.8.794
Sharma P, Prabhakar G, Garg A, Garg S, Singh V (2016) Animal model used for experimental study of diabetes mellitus: an overview. Asian J Biomater Res 2(4):99–110
Singh R, Farooq SA, Mannan A, Singh TG, Najda A, Grażyna Z, Albadrani GM, Sayed AA, Abdel-Daim MM (2022) Animal models of diabetic microvascular complications: relevance to clinical features. Biomed Pharmacother 145:112305. https://doi.org/10.1016/j.biopha.2021.112305
Skovsø S (2014) Modeling type 2 diabetes in rats using high fat diet and streptozotocin. J Diabetes Invest 5(4):349–358. https://doi.org/10.1111/jdi.12235
Slieker LJ, Sundell KL, Heath WF, Osborne HE, Bue J, Manetta J, Sportsman JR (1992) Glucose transporter levels in tissues of spontaneously diabetic Zucker fa/fa rat (ZDF/drt) and viable yellow mouse (Avy/a). Diabetes 41(2):187–193. https://doi.org/10.2337/diab.41.2.187
Srinivasan K, Ramarao P (2007) Animal models in type 2 diabetes research: an overview. Indian J Med Res 125(3):451–472
Stott NL, Marino JS (2020) High fat rodent models of type 2 diabetes: from rodent to human. Nutrients 12(12):3650. https://doi.org/10.3390/nu12123650
Szkudelski T (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50(6):537–546
Tarrés MC, Martinez SM, Montenegro S, Llorens A, Picena JC, Naves A (1992) The eSS rat. A model of non-insulin-dependent human diabetes. Am J Pathol 141(3):761–763
Tavakoli M, Quattrini C, Abbott C, Kallinikos P, Marshall A, Finnigan J, Morgan P, Efron N, Boulton AJ, Malik RA (2010) Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diabetes Care 33(8):1792–1797. https://doi.org/10.2337/dc10-0253
Teame T, Zhang Z, Ran C, Zhang H, Yang Y, Ding Q, Xie M, Gao C, Ye Y, Duan M, Zhou Z (2019) The use of zebrafish (Danio rerio) as biomedical models. Anim Front 9(3):68–77. https://doi.org/10.1093/af/vfz020
Tesfaye S (2009) Advances in the management of diabetic peripheral neuropathy. Curr Opin Support Palliat Care 3(2):136–143. https://doi.org/10.1097/SPC.0b013e32832b7df5
Thayer TC, Wilson SB, Mathews CE (2010) Use of nonobese diabetic mice to understand human type 1 diabetes. Endocrinol Metab Clin North Am 39(3):541–561. https://doi.org/10.1016/j.ecl.2010.05.001
Todd JA (2016) Intolerable secretion and diabetes in tolerant transgenic mice, revisited. Nat Genet 48(5):476–477. https://doi.org/10.1038/ng.3560
Utsugi T, Kanda T, Tajima Y, Tomono S, Suzuki T, Murata K, Dan K, Seto Y, Kawazu S (1992) A new animal model of non-insulin-dependent diabetes mellitus induced by the NDK25 variant of encephalomyocarditis virus. Diabetes Res (Edinburgh, Scotland) 20(4):109–119
Varier P, Raju G, Madhusudanan P, Jerard C, Shankarappa SA (2022) A brief review of in vitro models for injury and regeneration in the peripheral nervous system. Int J Mol Sci 23(2):816. https://doi.org/10.3390/ijms23020816
Ventura-Sobrevilla J, Boone-Villa VD, Aguilar CN, Román-Ramos R, Vega-Avila E, Campos-Sepúlveda E, Alarcón-Aguilar F (2011) Effect of varying dose and administration of streptozotocin on blood sugar in male CD1 mice. Proc West Pharmacol Soc 54:5–9
Vincent AM, Callaghan BC, Smith AL, Feldman EL (2011) Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol 7(10):573–583. https://doi.org/10.1038/nrneurol.2011.137
Wallis RH, Wang K, Marandi L, Hsieh E, Ning T, Chao GY, Sarmiento J, Paterson AD, Poussier P (2009) Type 1 diabetes in the BB rat: a polygenic disease. Diabetes 58(4):1007–1017. https://doi.org/10.2337/db08-1215
Wang R, Man Y, Zhou M, Zhu Y, Wang L, Yang J (2021) Neuropathic pain-induced cognitive dysfunction and down-regulation of neuronal pentraxin 2 in the cortex and hippocampus. Neuroreport 32(3):274–283. https://doi.org/10.1097/WNR.0000000000001584
Weiss H, Bleich A, Hedrich HJ, Kölsch B, Elsner M, Jörns A, Lenzen S, Tiedge M, Wedekind D (2005) Genetic analysis of the LEW.1AR1-iddm rat: an animal model for spontaneous diabetes mellitus. Mamm Genome 16(6):432–441. https://doi.org/10.1007/s00335-004-3022-8
Wexler BC, Iams SG, McMurtry JP (1980) Pathophysiological differences between obese and non-obese spontaneously hypertensive rats. Br J Exp Pathol 61(2):195–207
Wise PH, Weir BJ, Hime JM, Forrest E (1972) The diabetic syndrome in the tuco-tuco (Ctenomys talarum). Diabetologia 8(3):165–172. https://doi.org/10.1007/BF01212256
Wu J, Yan LJ (2015) Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicity. Diabetes Metab Syndr Obes 8:181–188. https://doi.org/10.2147/DMSO.S82272
Xu L, Tang D, Guan M, Xie C, Xue Y (2014) Effect of high-fat diet on peripheral neuropathy in C57BL/6 mice. Int J Endocrinol 2014:305205. https://doi.org/10.1155/2014/305205
Xue B, Sukumaran S, Nie J, Jusko WJ, Dubois DC, Almon RR (2011) Adipose tissue deficiency and chronic inflammation in diabetic Goto-Kakizaki rats. PloS One 6(2):e17386. https://doi.org/10.1371/journal.pone.0017386
Yang K, Yang X, Gao C, Hua C, Hong C, Zhu L (2021) A novel microfluidic device for the neutrophil functional phenotype analysis: effects of glucose and its derivatives AGEs. Micromachines (Basel) 12(8):944. https://doi.org/10.3390/mi12080944
Yokoi N, Kanazawa M, Kitada K, Tanaka A, Kanazawa Y, Suda S, Ito H, Serikawa T, Komeda K (1997) A non-MHC locus essential for autoimmune type I diabetes in the Komeda diabetes-prone rat. J Clin Invest 100(8):2015–2021. https://doi.org/10.1172/JCI119733
Yokoi N, Komeda K, Wang HY, Yano H, Kitada K, Saitoh Y, Seino Y, Yasuda K, Serikawa T, Seino S (2002) Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. Nat Genet 31(4):391–394. https://doi.org/10.1038/ng927
Yokoi N, Namae M, Fuse M, Wang HY, Hirata T, Seino S, Komeda K (2003) Establishment and characterization of the Komeda diabetes-prone rat as a segregating inbred strain. Exp Anim 52(4):295–301. https://doi.org/10.1538/expanim.52.295
Yokoi N, Hayashi C, Fujiwara Y, Wang HY, Seino S (2007) Genetic reconstitution of autoimmune type 1 diabetes with two major susceptibility genes in the rat. Diabetes 56(2):506–512. https://doi.org/10.2337/db06-1027
Yoon JW, Austin M, Onodera T, Notkins AL (1979) Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 300(21):1173–1179. https://doi.org/10.1056/NEJM197905243002102
Yoon JW, London WT, Curfman BL, Brown RL, Notkins AL (1986) Coxsackie virus B4 produces transient diabetes in nonhuman primates. Diabetes 35(6):712–716. https://doi.org/10.2337/diab.35.6.712
Zang Y, Jiang D, Zhuang X, Chen S (2023) Changes in the central nervous system in diabetic neuropathy. Heliyon 9(8):e18368. https://doi.org/10.1016/j.heliyon.2023.e18368
Zhang X, Xue R, Cao G, Pan Z, Zheng X, Gong C (2012) Silkworms can be used as an animal model to screen and evaluate gouty therapeutic drugs. J Insect Sci (Online) 12:4. https://doi.org/10.1673/031.012.0401
Zhu H, Yu L, He Y, Wang B (2014) Nonhuman primate models of type 1 diabetes mellitus for islet transplantation. J Diabetes Res 2014:785948. https://doi.org/10.1155/2014/785948
Ziv E, Shafrir E, Kalman R, Galer S, Bar-On H (1999) Changing pattern of prevalence of insulin resistance in Psammomys obesus, a model of nutritionally induced type 2 diabetes. Metabolism 48(12):1549–1554. https://doi.org/10.1016/s0026-0495(99)90244-5
Acknowledgements
Authors would like to acknowledge the support provided by Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Mesra.
Author information
Authors and Affiliations
Contributions
Each author of this research article has made substantial contributions to the conception, design, execution, and interpretation of the study. The individual contributions of each author are outlined as follows: Tanishk Saini: • Conducted data collection, ensuring the accuracy and reliability. • Drafted the initial version of the manuscript, ensuring scientific rigor and adherence to the journal's guidelines. • Provided critical revisions to the manuscript based on feedback from co-authors. • Modified the final version of the manuscript for submission and publication. Corresponding Author - Dr. (Mrs.) Papiya Mitra Mazumder: • Conceived and designed the study, outlining the objectives and methodology. • Coordinated and supervised the overall project, ensuring its smooth execution. • Handled correspondence with the journal editor, addressing queries and ensuring compliance with submission requirements. • Reviewed and approved the manuscript at each stage of revision, ensuring its completeness and accuracy. • Acted as the point of contact for the journal, addressing any revisions or additional information required during the peer review process. Both authors have equally contributed to the research and preparation of the manuscript, and they have read and approved the final version for submission. The authors confirm that no paper mill and artificial intelligence was used.
Corresponding author
Ethics declarations
Ethical approval
Not applicable
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Tanishk Saini is the first author.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Saini, T., Mazumder, P.M. Current advancement in the preclinical models used for the assessment of diabetic neuropathy. Naunyn-Schmiedeberg's Arch Pharmacol 397, 2727–2745 (2024). https://doi.org/10.1007/s00210-023-02802-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-023-02802-0